Abstract:Baculovirus-mediated expression in insect cells has become well-established for the production of recombinant glycoproteins. Its frequent use arises from the relative ease and speed with which a heterologous protein can be expressed on the laboratory scale and the high chance of obtaining a biologically active protein. In addition to Spodoptera frugiperda Sf9 cells, which are probably the most widely used insect cell line, other mainly lepidopteran cell lines are exploited for protein expression. Recombinant baculovirus is the usual vector for the expression of foreign genes but stable transfection of - especially dipteran - insect cells presents an interesting alternative. Insect cells can be grown on serum free media which is an advantage in terms of costs as well as of biosafety. For large scale culture, conditions have been developed which meet the special requirements of insect cells. With regard to protein folding and post-translational processing, insect cells are second only to mammalian cell lines. Evidence is presented that many processing events known in mammalian systems do also occur in insects. In this review, emphasis is laid, however, on protein glycosylation, particularly N-glycosylation, which in insects differs in many respects from that in mammals. For instance, truncated oligosaccharides containing just three or even only two mannose residues and sometimes fucose have been found on expressed proteins. These small structures can be explained by post-synthetic trimming reactions. Indeed, cell lines having a low level of N-acetyl-beta-glucosaminidase, e.g. Estigmene acrea cells, produce N- glycans with non-reducing terminal N-acetylglucosamine residues. The Trichoplusia ni cell line TN-5B1-4 was even found to produce small amounts of galactose terminated N-glycans. However, there appears to be no significant sialylation of N-glycans in insect cells. Insect cells expressed glycoproteins may, though, be alpha1,3-fucosylated on the reducing-terminal GlcNAc residue. This type of fucosylation renders the N-glycans on one hand resistant to hydrolysis with PNGase F and on the other immunogenic. Even in the absence of alpha1,3-fucosylation, the truncated N-glycans of glycoproteins produced in insect cells constitute a barrier to their use as therapeutics. Attempts and strategies to "mammalianise" the N-glycosylation capacity of insect cells are discussed.

An economic approach to isotopic enrichment of glycoproteins expressed from Sf9 insect cells

A Transgenic Bm Cell Line of Piggybac Transposon-Derived Targeting Expression of Humanized Glycoproteins Through N-glycosylation.

Counter-intuitive method improves yields of isotopically-labeled proteins expressed in flask-cultured

Uniform [13C,15N]-labeled and glycosylated IgG1 Fc expressed in Saccharomyces cerevisiae

Efficient and economic protein labeling for NMR in mammalian expression systems: Application to a preT‐cell and T‐cell receptor protein

Insect cells as hosts for the expression of recombinant glycoproteins

Stable isotope labeling approaches for NMR characterization of glycoproteins using eukaryotic expression systems

An Efficient Approach for Large-Scale Production of Sialyglycopeptides from Egg Yolks

Improving yields of deuterated, methyl labeled protein by growing in H2O

Utilization of glucose and amino acids in insect cell cultures: Quantifying the metabolic flows within the primary pathways and medium development

The synthesis of specifically isotope labelled fluorotryptophan and its use in mammalian cell-based protein expression for 19F-NMR applications

Heterologous high yield expression and purification of neurotensin and its functional fragment in Escherichia coli

Sandwiched‐fusion Strategy Facilitates Recombinant Production of Small Labile Proteins

Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris

Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery

Expression and characterization of human N-acetylglucosaminyltransferases and alpha2,3-sialyltransferase in insect cells for in vitro glycosylation of recombinant erythropoietin.

In Vivo Optimizing of Intracellular Production of Heterologous Protein in Pichia Pastoris by Fluorescent Scanning.

Improving cell-free glycoprotein synthesis by characterizing and enriching native membrane vesicles

Isotopic Labeling of Proteins by Utilizing Photosynthetic Bacteria

Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins

Enhanced N-glycosylation site exploitation of sialoglycopeptides by peptide IPG-IEF assisted TiO 2 chromatography